E-LIB Suche - Ergebnisse für: Jardin, F.

1

Valeur pronostique de la combinaison des paramètres de volu..:

Draye Carbonnier, S. ; Camus, V. ; Becker, S....
Médecine Nucléaire. 48 (2024) 2 - p. 83 , 2024

Link: https://doi.org/10.1016/..

2

Prognostic value of the combination of volume, massiveness ..:

Draye-Carbonnier, S. ; Camus, V. ; Becker, S....
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG ..:

Sarkozy, C. ; Thieblemont, C. ; Oberic, L....
Hematological Oncology. 41 (2023) S2 - p. 151-152 , 2023

Link: https://doi.org/10.1002/..

4

REALMA: Subset of patients with Marginal Zone Lymphomas fro..:

Bommier, C. ; Donzel, M. ; Rossi, C....
Hematological Oncology. 41 (2023) S2 - p. 387-388 , 2023

Link: https://doi.org/10.1002/..

5

MOLECULAR CHARACTERIZATION CONTRIBUTES TO DIAGNOSIS AND PRE..:

Camus, V. ; Viailly, P. ; Sesques, P....
Hematological Oncology. 41 (2023) S2 - p. 110-111 , 2023

Link: https://doi.org/10.1002/..

6

IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO ..:

Morschhauser, F. ; Hatzi, K. ; Lenz, G....
Hematological Oncology. 41 (2023) S2 - p. 223-225 , 2023

Link: https://doi.org/10.1002/..

7

Prognostic Value of Lymphopenia and Total Metabolic Tumor V..:

Willaume, A. ; Chartier, L. ; Ricci, R....
Hematological Oncology. 41 (2023) S2 - p. 346-347 , 2023

Link: https://doi.org/10.1002/..

8

Neutropénies associées aux anticorps anti-cytoplasme des po..:

Fournier, M. ; Sicre De Fontbrune, F. ; Coppo, P....
La Revue de Médecine Interne. 44 (2023) - p. A88 , 2023

Link: https://doi.org/10.1016/..

9

COMBINING BASELINE TOTAL METABOLIC TUMOR VOLUME AND BETA‐2‐..:

Zduniak, A. ; Lévêque, E. ; Draye‐Carbonnier, S....
Hematological Oncology. 41 (2023) S2 - p. 670-671 , 2023

Link: https://doi.org/10.1002/..

10

CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES ..:

Herrera, A. F. ; Tracy, S. ; Sehn, L. H....
Hematological Oncology. 41 (2023) S2 - p. 175-177 , 2023

Link: https://doi.org/10.1002/..

11

Effect of single-unit transfusion in patients treated for h..:

Chantepie, S.P. ; Mear, J.B. ; Briant, A.R....
Leukemia Research. 129 (2023) - p. 107058 , 2023

Link: https://doi.org/10.1016/..

12

AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐..:

Houot, R. ; Bachy, E. ; Cartron, G....
Hematological Oncology. 41 (2023) S2 - p. 147-148 , 2023

Link: https://doi.org/10.1002/..

13

Long‐term analysis of the RiBVD phase II trial reveals the ..:

Carras, S. ; Torroja, A. ; Emadali, A....
Hematological Oncology. 41 (2023) S2 - p. 481-483 , 2023

Link: https://doi.org/10.1002/..

14

P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMEN..:

Morschhauser, F. ; Jiang, Y. ; Jardin, F....
HemaSphere. 6 (2022) - p. 1076-1077 , 2022

Link: https://doi.org/10.1097/..

15

P1186: A LARGE FRENCH REAL WORLD MULTICENTRIC PROSPECTIVE C..:

Ghesquieres, H. ; Cherblanc, F. ; Belot, A....
HemaSphere. 6 (2022) - p. 1072-1073 , 2022

Link: https://doi.org/10.1097/..